Skip to main content
. Author manuscript; available in PMC: 2018 May 3.
Published in final edited form as: Antivir Ther. 2017;22(8):659–668. doi: 10.3851/IMP3155

Table 2. Patient characteristics (continuous variables) at baseline by cohort.

N MEAN SD MEDIAN LQ UQ
Age
 OVERALL 3211 37.91 10.09 36.38 30.61 43.46
 AHOD 591 41.63 10.28 40.91 34.39 47.64
 TAHOD 2620 37.07 9.86 35.55 30.09 42.19
Baseline (BL) CD4:CD8
 OVERALL 3211 0.26 0.25 0.20 0.10 0.33
 AHOD 591 0.39 0.37 0.30 0.19 0.48
 TAHOD 2620 0.22 0.20 0.18 0.09 0.30
Baseline CD4 (cells/mm3)
 OVERALL 3211 207.34 186.69 178 68 284
 AHOD 591 342.43 237.90 290 197 446
 TAHOD 2620 176.87 157.87 152 54 255
Baseline CD8 (cells/mm3)
 OVERALL 3211 883.30 503.79 792 514 1160
 AHOD 591 1022.89 538.15 930 650 1273
 TAHOD 2620 851.81 490.36 770 489 1124